Menu
GWAS Study

A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study.

Schmit SL, Schumacher FR, Edlund CK et al.

25023989 PubMed ID
GWAS Study Type
5921 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SS
Schmit SL
SF
Schumacher FR
EC
Edlund CK
CD
Conti DV
RL
Raskin L
LF
Lejbkowicz F
PM
Pinchev M
RH
Rennert HS
JM
Jenkins MA
HJ
Hopper JL
BD
Buchanan DD
LN
Lindor NM
LM
Le Marchand L
GS
Gallinger S
HR
Haile RW
NP
Newcomb PA
HS
Huang SC
RG
Rennert G
CG
Casey G
GS
Gruber SB
Chapter II

Abstract

Summary of the research findings

Only a fraction of colorectal cancer heritability is explained by known risk-conferring genetic variation. This study was designed to identify novel risk alleles in Europeans. We conducted a genome-wide association study (GWAS) meta-analysis of colorectal cancer in participants from a population-based case-control study in Israel (n = 1616 cases, 1329 controls) and a consortium study from the Colon Cancer Family Registry (n = 1977 cases, 999 controls). We used a two-stage (discovery-replication) GWAS design, followed by a joint meta-analysis. A combined analysis identified a novel susceptibility locus that reached genome-wide significance on chromosome 4q32.2 [rs35509282, risk allele = A (minor allele frequency = 0.09); odds ratio (OR) per risk allele = 1.53; P value = 8.2 × 10(-9); nearest gene = FSTL5]. The direction of the association was consistent across studies. In addition, we confirmed that 14 of 29 previously identified susceptibility variants were significantly associated with risk of colorectal cancer in this study. Genetic variation on chromosome 4q32.2 is significantly associated with risk of colorectal cancer in Ashkenazi Jews and Europeans in this study.

485 Ashkenazi Jewish cases, 498 Ashkenazi Jewish controls, 1,977 European ancestry cases, 999 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

5921
Total Participants
GWAS
Study Type
Yes
Replicated
1,131 Ashkenazi Jewish cases, 831 Ashkenazi Jewish controls
Replication Participants
Other, European
Ancestry
Israel, U.S., Australia, Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.